Theragen Etex Co.,Ltd.

A066700

KR7066700006

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
3,910 ^KRW	+0.13%		-0.38%	-12.53%

2023	MedPacto, Inc. announced that it has received KRW 10.85806127 billion in funding from Theragen Etex Co.,Ltd.	CI
2023	MedPacto, Inc. announced that it expects to receive KRW 11.95668467 billion in funding from Theragen Etex Co.,Ltd.	CI

Theragen Etex Co.,Ltd. announced that it has received KRW 20 billion in funding

October 25, 2018

On October 25, 2018, Theragen Etex Co.,Ltd. (KOSDAQ:A066700) closed the transaction.

Latest news about Theragen Etex Co.,Ltd.

MedPacto, Inc. announced that it has received KRW 10.85806127 billion in funding from Theragen Etex Co.,Ltd.	15/12	CI
MedPacto, Inc. announced that it expects to receive KRW 11.95668467 billion in funding from Theragen Etex Co.,Ltd.	23/11	CI
Theragen Etex Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Theragen Etex Co.,Ltd. announced that it has received KRW 20 billion in funding	25/18/25	CI
Theragen Etex Co.,Ltd. announced that it expects to receive KRW 20 billion in funding	23/18/23	CI
Oncotherapy Science, Inc. and Theragen Etex Co.,Ltd., to Form Joint Venture Company	14/17/14	CI
Theragen Etex Co.,Ltd. announced that it has received KRW 10.65 billion in funding	23/16/23	CI
Theragen Etex Co.,Ltd. announced that it expects to receive KRW 10.65 billion in funding	22/16/22	CI

THERAGEN ETEX CO.LTD. is a Korea-based company engaged in the industrial equipment business, healthcare and genome business and pharmaceutical business. The Company operates its business through three divisions: flat panel display (FPD) manufacturing equipment division, which provides loading and unloading systems, printed circuit board (PCB) bonding systems, battery washing lines and laser systems; healthcare and genome division engages in the provision of genome analysis services and others, and pharmaceutical division engages in the manufacture of digestive system remedies, antibiotics, remedies for fever, circulatory system remedies, respiration system remedies, treatment for chronic hepatitis, diabetes remedies, psychotropic agents, osteoporosis treatments and others.

Sector

Pharmaceuticals

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
THERAGEN ETEX CO.,LTD.	-12.53%	92.11M
ELI LILLY AND COMPANY	+38.59%	727B
JOHNSON & JOHNSON	-7.89%	347B
MERCK & CO., INC.	+15.66%	319B
ABBVIE INC.	+0.24%	274B
ASTRAZENECA PLC	+13.15%	238B
NOVARTIS AG	+6.98%	204B
ROCHE HOLDING AG	-6.50%	203B
AMGEN INC.	+4.23%	161B
PFIZER, INC.	-1.70%	160B